Thermo Fisher Scientific Inc.
TMO 448.28 (0.00%) 0.00
Health Care
Life Sciences Tools and Services
Quality Checklist 5/8
5Y Shares Out Change < 0%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $166.59(B)
EV: $206.62(B)
Total Equity: $52.06(B)
Earnings date: Apr-22-2026
P/E: 24.58
Forward P/E: 18.02
P/FCF: 24.69
P/S: 3.72
P/B: 3.21
EPS: $18.2
EPS (fwd): $24.9
FCF/share: $18.2
Revenue/share: $120.4
Book value/share: $139.8
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Debt/Equity: 0.83
Current Ratio: 1.50
Gross margin: 40.9%
Operating margin: 18.4%
Net margin: 15.2%
Dividend/share: $1.8
Div. yield: 0.39%
TTM Financials
Income (TTM)
Revenue$45.20(B)
Gross profit$18.50(B)
EBITDA$11.30(B)
Net income$6.85(B)
Gross margin40.9%
Operating margin18.4%
Net margin15.2%
Shares outstanding371.62(M)
Balance sheet
Total assets$113.28(B)
Current assets$22.32(B)
Total liabilities$61.22(B)
Current liabilities$14.62(B)
Cash & Short-term inv.$3.26(B)
Long-term debt$39.86(B)
Total intangibles$74.33(B)
PP&E$10.66(B)
Cash flow (TTM)
FCF$6.75(B)
CapEx$-1.54(B)
Dividends paid$-649.00(M)
Stock issued$0
Stock repurchased$-4.00(B)
Stock-based comp.$318.00(M)
Debt issued$11.64(B)
Debt repaid$-4.08(B)